Affymax to create multiple presentations on preclinical and clinical data of Hematide Affymax.

Lafayette shall provide background on managing anemia in sufferers with chronic kidney disease. Dr. MacDougall will discuss real reddish colored cell aplasia a rare, serious and debilitating autoimmune disorder, which can occur when the physical body produces neutralizing antibodies to the currently marketed recombinant human erythropoietins.. Affymax to create multiple presentations on preclinical and clinical data of Hematide Affymax, Inc. today announced multiple presentations at the American Society of Nephrology Renal Week 2009 taking place October 27 through November 1 in San Diego. Affymax and investigators will make multiple presentations highlighting Hematide preclinical and scientific data in various treatment settings.The use of clever pumps, barcode-assisted medication administration, computerized prescriber order entry systems, and digital health record systems also continues to grow in hospitals of all sizes. Pharmacists’ motion into more direct patient care functions combined with the widespread use of medication-make use of technology are improving effectiveness, safety, and scientific outcomes, regarding to authors Craig A. Pedersen, B.S.Pharm., Ph.D., FAPhA; Philip J. Schneider, M.S., FASHP, FFIP, FASPEN; and Douglas J. Scheckelhoff, M.S., FASHP. The survey of just one 1,435 pharmacy directors who just work at general and children’s medical-surgical hospitals in the U.S.